Cite

HARVARD Citation

    Wei, W. et al. (2022). Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis. Pharmacological research. p. . [Online]. 
  
Back to record